Articles

Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis

Departments of Hematology/Oncology, Boston University School of Medicine, MA, USA;Amyloidosis Center, Boston University School of Medicine, MA, USA
Medicine, Boston University School of Medicine, MA, USA
Department of Biostatistics, Boston University School of Public Health, MA, USA
Nephrology, Boston University School of Medicine, MA, USA;Amyloidosis Center, Boston University School of Medicine, MA, USA
Nephrology, Boston University School of Medicine, MA, USA;Amyloidosis Center, Boston University School of Medicine, MA, USA
Pulmonology, Boston University School of Medicine, MA, USA;Amyloidosis Center, Boston University School of Medicine, MA, USA
Departments of Hematology/Oncology, Boston University School of Medicine, MA, USA;Amyloidosis Center, Boston University School of Medicine, MA, USA
Departments of Hematology/Oncology, Boston University School of Medicine, MA, USA;Amyloidosis Center, Boston University School of Medicine, MA, USA
Departments of Hematology/Oncology, Boston University School of Medicine, MA, USA;Amyloidosis Center, Boston University School of Medicine, MA, USA
Vol. 101 No. 1 (2016): January, 2016 https://doi.org/10.3324/haematol.2015.133900